Vimta Labs Ltd

Vimta Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vimta Labs Ltd

₹ 999 -3.73%
30 Apr - close price
vimta.com BSE: 524394 NSE: VIMTALABS
About

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]

Key Points

Business Overview:[1]
VLL is is in the business of contract research and testing in the fields of biologics, small molecules, agro -chemicals, food & beverages, electronics, clinical diagnostics, medical devices, home and personal care products, and environment testing

Website BSE NSE
  • Market Cap ₹ 2,221 Cr.
  • Current Price ₹ 999
  • High / Low ₹ 1,183 / 420
  • Stock P/E 33.3
  • Book Value ₹ 170
  • Dividend Yield 0.20 %
  • ROCE 25.2 %
  • ROE 19.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Miscellaneous

Part of BSE Allcap BSE Healthcare BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
74 79 79 76 81 82 64 73 73 73 83 90 94
51 55 54 55 57 58 48 50 47 48 54 57 61
Operating Profit 23 24 25 21 24 24 17 23 26 25 29 33 33
OPM % 31% 30% 32% 27% 29% 29% 26% 31% 36% 34% 35% 37% 35%
0 1 1 1 1 1 0 -1 -1 -1 -1 5 2
Interest 1 1 1 1 0 0 1 1 1 0 0 1 0
Depreciation 7 7 8 8 8 8 9 8 8 8 8 10 9
Profit before tax 16 17 18 14 16 16 8 13 16 16 19 28 25
Tax % 27% 27% 26% 27% 23% 25% 25% 25% 24% 26% 24% 23% 27%
12 12 13 10 12 12 6 9 12 12 15 22 18
EPS in Rs 5.37 5.44 5.91 4.50 5.54 5.25 2.67 4.27 5.57 5.25 6.58 9.68 8.24
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
127 116 138 154 183 213 181 209 276 315 313 344
101 99 119 127 138 155 151 156 196 222 229 222
Operating Profit 26 17 19 27 45 58 30 53 80 94 84 122
OPM % 20% 15% 14% 18% 25% 27% 17% 25% 29% 30% 27% 35%
3 1 1 1 1 2 3 1 0 3 4 5
Interest 2 1 1 2 5 5 4 2 2 3 2 2
Depreciation 9 11 10 10 16 20 21 23 23 31 34 35
Profit before tax 18 7 8 17 26 35 8 28 55 64 52 90
Tax % 25% 24% 23% 36% 36% 28% 17% 25% 26% 26% 25% 25%
13 5 6 11 16 25 7 21 41 47 39 67
EPS in Rs 5.99 2.29 2.91 4.79 7.43 11.45 3.13 9.62 18.57 21.37 17.51 30.29
Dividend Payout % 33% 44% 34% 0% 27% 17% 0% 21% 11% 9% 11% 7%
Compounded Sales Growth
10 Years: 11%
5 Years: 14%
3 Years: 8%
TTM: 10%
Compounded Profit Growth
10 Years: 29%
5 Years: 58%
3 Years: 17%
TTM: 74%
Stock Price CAGR
10 Years: 30%
5 Years: 66%
3 Years: 40%
1 Year: 86%
Return on Equity
10 Years: 14%
5 Years: 17%
3 Years: 17%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves 116 118 122 132 148 167 169 190 229 276 312 374
7 4 26 44 40 26 32 30 19 15 19 9
22 21 23 42 40 40 39 49 54 65 61 79
Total Liabilities 149 146 176 222 232 237 245 273 306 360 396 467
90 88 88 88 140 135 131 128 162 168 163 230
CWIP 2 0 6 53 0 4 2 17 0 12 59 38
Investments 0 0 0 0 0 0 6 6 6 6 6 0
57 58 82 80 92 99 105 122 138 174 168 198
Total Assets 149 146 176 222 232 237 245 273 306 360 396 467

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
17 15 -1 24 33 39 24 37 59 87 59 95
-8 -8 -16 -39 -24 -16 -20 -32 -38 -57 -75 -76
-8 -9 19 13 -8 -23 -1 -5 -16 -11 -2 -17
Net Cash Flow 0 -1 2 -2 1 1 3 1 5 19 -17 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 81 82 100 101 111 100 117 128 102 93 101 113
Inventory Days 175 158 213 183 209 199 191 140 115 187 185 129
Days Payable 87 66 77 184 148 115 114 139 81 119 61 54
Cash Conversion Cycle 169 174 236 100 172 184 194 128 136 160 224 188
Working Capital Days 84 120 126 68 88 87 100 116 96 84 102 102
ROCE % 16% 6% 7% 11% 17% 21% 6% 14% 24% 24% 17% 25%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
37.46% 37.46% 37.26% 37.25% 37.23% 37.00% 36.98% 36.92% 36.89% 36.89% 36.76% 36.70%
0.35% 0.49% 2.28% 2.25% 2.72% 2.74% 2.88% 5.13% 5.16% 3.31% 3.81% 3.66%
2.01% 2.04% 2.13% 2.14% 2.14% 1.50% 1.49% 1.50% 1.49% 0.00% 1.15% 1.43%
60.18% 60.02% 58.35% 58.37% 57.92% 58.75% 58.65% 56.45% 56.45% 59.80% 58.28% 58.20%
No. of Shareholders 18,10618,28318,91617,16217,43918,42919,95718,55019,05420,11421,15626,183

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls